Skip to main content
View Cart

European Journal of Pharmaceutics and Biopharmaceutics

  • Annual issues: 12 volumes, 12 issues

  • ISSN: 0939-6411

Official journal of the International Association for Pharmaceutical TechnologyThe European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publica… Read more

Subscription options

Subscription options

Institutional subscription on ScienceDirect

Request a sales quote

Official journal of the International Association for Pharmaceutical Technology

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.

Topics covered include for example:

  • Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)

  • Aspects of manufacturing process design

  • Biomedical aspects of drug product design

  • Strategies and formulations for controlled drug transport across biological barriers

  • Physicochemical aspects of drug product development

  • Novel excipients for drug product design

  • Drug delivery and controlled release systems for systemic and local applications

  • Nanomaterials for therapeutic and diagnostic purposes

  • Advanced therapy medicinal products

  • Medical devices supporting a distinct pharmacological effect

"The Rules of 3"

The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:

  • The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance.

  • The paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.

  • The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.